Amgen (AMGN) Gross Margin (2016 - 2025)
Historic Gross Margin for Amgen (AMGN) over the last 17 years, with Q4 2025 value amounting to 69.84%.
- Amgen's Gross Margin rose 40900.0% to 69.84% in Q4 2025 from the same period last year, while for Dec 2025 it was 67.25%, marking a year-over-year increase of 57200.0%. This contributed to the annual value of 67.25% for FY2025, which is 57200.0% up from last year.
- Per Amgen's latest filing, its Gross Margin stood at 69.84% for Q4 2025, which was up 40900.0% from 67.75% recorded in Q3 2025.
- In the past 5 years, Amgen's Gross Margin registered a high of 77.1% during Q2 2022, and its lowest value of 57.03% during Q1 2024.
- Its 5-year average for Gross Margin is 69.93%, with a median of 72.83% in 2023.
- In the last 5 years, Amgen's Gross Margin crashed by -148000bps in 2024 and then skyrocketed by 66800bps in 2025.
- Over the past 5 years, Amgen's Gross Margin (Quarter) stood at 74.91% in 2021, then dropped by -1bps to 74.46% in 2022, then fell by -17bps to 62.03% in 2023, then increased by 6bps to 65.75% in 2024, then increased by 6bps to 69.84% in 2025.
- Its Gross Margin was 69.84% in Q4 2025, compared to 67.75% in Q3 2025 and 67.2% in Q2 2025.